Biotech

InspireMD announced the endovascular interventional procedure which features the CGuard EPS was recorded and presented at this year’s SOLACI CACI Congress of Cardiology.

InspireMD (NYSEMKT:NSPR) announced the endovascular interventional procedure which features the CGuard EPS was recorded and presented at this year’s SOLACI CACI Congress of Cardiology.
As quoted in the press release:

The case, entitled “Self Expanding Stent to Avoid Distal Embolization: Carotid InspireMD Stent Case presentation,” was displayed to the entire congress.
SOLACI CACI ’17 is the official annual meeting of the Latin American Society of Interventional Cardiology and the Argentinian School of Interventional Cardiologists, and is the largest meeting of cardiologists and interventional cardiologists in Latin America. SOLACI CACI ’17 is taking place from August 2-4, 2017.
Dr. Anibal Damonte, commented, “The CGuard™ EPS performed exceedingly well in a challenging case. The MicroNet™ technology enables us to treat carotid artery disease safely in cases that would not have been possible with conventional carotid stents.”

Click here to read the full press release.

Source: www.marketwired.com

Featured

MARKETS

Markets
TSX20206.41+106.60
TSXV700.54+3.89
DOW32223.42+26.76
S&P 5004008.01-15.88
NASD11662.79-142.21
ASX7093.00+17.90

COMMODITIES

Commodities
Gold1828.73+1.48
Silver21.67+0.06
Copper4.23+0.04
Palladium2018.00+8.00
Platinum948.50+3.50
Oil114.17-0.03
Heating Oil3.77-0.01
Natural Gas8.06+0.10

DOWNLOAD FREE REPORTS

×